In response to growing concerns about misleading health information, Indian authorities have issued a strict warning to pharmaceutical companies regarding the promotion of weight-loss drugs. Regulators have emphasized that direct or surrogate advertising of prescription medications is prohibited under existing laws.
Officials are particularly concerned that aggressive marketing campaigns may create unrealistic expectations among consumers while downplaying the importance of healthy lifestyle changes. With obesity rates rising steadily, experts warn that reliance on medication without proper medical supervision could lead to adverse health outcomes.
The advisory reinforces the need for ethical communication in the healthcare sector and encourages individuals to consult qualified medical professionals before considering any weight-loss treatment. Authorities continue to stress that sustainable weight management should be based on balanced nutrition, regular physical activity, and long-term lifestyle changes.
